8-K current report · filed Aug 4, 2026

ASP Isotopes Inc. (ASPI) 8-K Current Report: August 4, 2026

Item EX-99.1Item 7.01Item 2.02ASPI overview

Short answer

ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on August 4, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure), Item 2.02 (Results of Operations and Financial Condition). Shareholder letter issued August 4, 2026, providing investors with management’s current company update.

ASP Isotopes Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Shareholder letter issued August 4, 2026, providing investors with management’s current company update
  • Exhibit 99.1 contains the substantive disclosure and should be reviewed for operating developments and outlook

Item 7.01 · Regulation FD Disclosure

  • Item 7.01 incorporates the Item 2.02 earnings disclosure by reference
  • Investor-relevant information is contained in the Item 2.02 exhibit rather than this section

Item EX-99.1 · Exhibit EX-99.1

  • PET Labs 1H 2026 organic revenue growth exceeded 50%; FY 2026 revenue forecast approximately $14 million versus $6 million in 2025
  • Renergen helium production targeted before September 30, 2026, with Phase 1 annualized revenue forecast above $27 million
  • Phase 2 expected to receive approximately $750 million senior debt funding, subject to definitive agreements
  • Noble Africa reverse merger could create Nasdaq-listed helium company; ASPI expected to retain approximately 89% ownership
  • Management reiterates 2031 EBITDA target above $300 million, but projections remain subject to execution and unavailable GAAP reconciliation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ASP Isotopes Inc. 8-K filings

Get the next ASPI 8-K as it lands

Follow ASPI for push alerts, or ask the research agent what this filing means.